The third one in China: Lu Kang medicine received the approval for drug registration of calcium acetate granules

On January 11, Lu Kang medicine announced that it had received the approval document for drug registration of calcium acetate granules issued by the State Food and drug administration At present, Kunming BANGYU Pharmaceutical Co., Ltd and Henan Nome Pharmaceutical Co., Ltd have been approved to produce calcium acetate granules in China, which is the third approved company Table 1: basic information of drug approval documents Source: company announcement According to the announcement, calcium acetate belongs to organic calcium acid, which has the advantages of better solubility than inorganic calcium acid, close to neutral pH value and less gastrointestinal stimulation The product is used for the prevention and treatment of calcium deficiency, such as osteoporosis, hand foot convulsion, bone hypoplasia, rickets and calcium supplement for children, pregnant and lactating women, menopausal women and the elderly Figure 1: Sales of terminal chemical calcium acetate granules in public medical institutions in China (unit: 10000 yuan) Source: the terminal competition pattern of Chinese public medical institutions in the Internet According to the data of mienei.com, in 2018, calcium acetate granules ranked 14th among the top 20 mineral supplement products for domestic use in China's urban public hospitals, county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions), and the sales volume of the product also exceeded 117 million yuan Figure 2: approval of calcium acetate granules Source: one click search on the Internet At present, Kunming BANGYU Pharmaceutical Co., Ltd and Henan nomy Pharmaceutical Co., Ltd have obtained the approval for calcium acetate granules production, and Lukang Pharmaceutical Co., Ltd has become the third approved enterprise for this product Lu said the company invested about 1.74 million yuan (Unaudited) in the research and development of the drug.